Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Department of Dermatology, Saitama Cancer Center, 780 Komuro, Ina, Kitaadachi-gun, Saitama 362-0806, Japan.
Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Eur J Surg Oncol. 2018 Jun;44(6):823-829. doi: 10.1016/j.ejso.2018.02.246. Epub 2018 Mar 6.
In patients with cutaneous angiosarcoma of the scalp and face, the validity of surgery remains controversial, because of the potentially diffuse nature of involvement and difficulty in obtaining negative margins.
To evaluate the survival benefit of surgery as a primary treatment.
Fifty-one patients with primary cutaneous angiosarcoma of the scalp and face presenting with locoregional involvement were referred to National Cancer Center Hospital, Tokyo, Japan, between May 1982 and March 2013. Data of those patients in whom the diagnosis had been confirmed histologically and the primary treatments had been initiated at our center were analysed retrospectively. Only untreated cases were selected with aim to evaluate actual survival benefit of surgery as a primary treatment.
Of the 51 patients, 38 were found to be eligible for inclusion in this analysis; of these 38 patients, 29 (29/38 = 76.3%) patients had tumour diameter > 5 cm, and 29 underwent surgery with curative intent (curative-intent surgery) as the initial treatment. Histologically positive margins were found in 10 patients. Multivariate analysis identified curative-intent surgery as being significantly associated with improved overall survival (OS; HR = 0.26; 95% CI, 0.10-0.63). In the Surgery group, neither negative margins nor combined-modality treatment had any significant influence on the OS.
Removal of primary tumour with curative-intent surgery may be a valid treatment option even for patients with primary cutaneous angiosarcoma of the scalp and face larger than 5 cm in size, regardless of the histological surgical margin status.
头皮和面部皮肤血管肉瘤患者的手术有效性存在争议,因为病变可能呈弥漫性且难以获得阴性切缘。
评估手术作为初始治疗的生存获益。
1982 年 5 月至 2013 年 3 月期间,51 例头皮和面部原发性皮肤血管肉瘤局部区域受累患者转诊至日本东京国家癌症中心医院。对在我院确诊并接受初始治疗的患者进行回顾性数据分析。本研究仅选择未经治疗的病例,旨在评估手术作为初始治疗的实际生存获益。
51 例患者中,有 38 例符合纳入本分析的条件;这 38 例患者中,29 例(29/38=76.3%)肿瘤直径>5cm,29 例患者接受了以治愈为目的的手术(根治性手术)作为初始治疗。10 例患者的切缘阳性。多因素分析显示,以治愈为目的的手术与总生存(OS)改善显著相关(HR=0.26;95%CI,0.10-0.63)。在手术组中,阴性切缘或联合治疗对 OS 均无显著影响。
对于直径大于 5cm 的头皮和面部皮肤血管肉瘤患者,即使切缘阳性,根治性手术切除原发肿瘤也可能是一种有效的治疗选择。